OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F2634 to DMS PHARMACEUTICAL GROUP INC, with an award date of July 21, 2026, under the parent contract SPE2DX25D9900. The award is for the procurement of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, though the total contract value is specified to be found in the official award documentation. The contract falls under federal procurement authority and is administered by the Department of Defense through the DLA, with no set-aside designation applied. Performance is expected to support federal requirements, though specific delivery locations are not detailed. The contract information is accessible via the DIBBS portal using the provided UI link for official records and updates.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
